Skip to main content
Erschienen in: Pediatric Nephrology 3/2021

30.06.2020 | Clinical Quiz

A rare case of hyporeninemic hypertension: Answers

verfasst von: Ahmad Mashmoushi, Abha Choudhary, Christie P. Thomas, Matthias T. F. Wolf

Erschienen in: Pediatric Nephrology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Excerpt

All the conditions listed below result in volume expansion and subsequent suppression of renin secretion.
I.
Liddle’s syndrome: autosomal dominant inheritance, gain-of-function variants of SCNN1B or SCNN1G, encoding the beta and gamma subunits of the epithelial Na+ channel ENaC, respectively. This results in less channel ubiquitination, higher cell surface abundance of ENaC in the connecting tubule and collecting ducts, and more Na+ and water absorption [1, 2].
 
II.
Gordon syndrome (pseudohypoaldosteronism type 2): autosomal dominant inheritance, WNK1, WNK4, CUL1, and KLHL1 (KLHL1 is also inherited in an autosomal recessive manner). Clinical and laboratory characteristics include hyperkalemia, metabolic acidosis, and hypercalciuria. Large deletions within the first intron of the WNK1 gene result in increased WNK1 expression which stimulates NCC. KLHL3 and CUL3 are part of an ubiquitin-protein ligase complex which degrades WNKs. Loss-of-function variants in KLHL3 and CUL3 cause an increased abundance of WNK4 which stimulates NCC [35]. Gain-of-function variants in WNK4 also increase NCC activity [5].
 
III.
Apparent mineralocorticoid excess (AME): autosomal recessive inheritance, due to inactivating variants of HSD11B2 encoding the 11β-hydroxysteroid dehydrogenase type 2 enzyme. Under normal circumstances, both aldosterone and cortisol bind to mineralocorticoid receptors (MR), but cortisol is 100-fold more abundant in the circulation than aldosterone [6]. This enzyme converts cortisol to the inactive hormone cortisone and thereby protects the MR from cortisol action. Inactivating mutations causes an excess of cortisol to bind to MR and MR stimulation in the collecting ducts leading to aldosterone-like effects [7].
 
IV.
Hypertension exacerbated by pregnancy: autosomal dominant inheritance, gain-of-function variants of MR resulting in higher sensitivity to non-mineralocorticoid steroids causing enhanced Na+ absorption in the distal nephron. The name of this disorder is misleading since the phenotype is not limited to pregnancy or females [8].
 
V.
Glucocorticoid remediable aldosteronism (GRA) or familial hyperaldosteronism type 1: autosomal dominant inheritance, due to an unequal crossover (nonallelic homologous recombination) between the genes encoding 11β-hydroxylase and aldosterone synthase. This creates a hybrid fusion gene containing an ACTH-responsive promoter and an aldosterone synthase coding region, which responds to ACTH [9].
 
VI.
Congenital adrenal hyperplasia (CAH): autosomal recessive, caused either by inactivating mutations of 11β-hydroxylase (CYP11B1) or 17α-hydroxylase (CYP17) [10, 11]. This leads to accumulation of steroid precursors including deoxycorticosterone which activate mineralocorticoid receptor.
 
VII.
Other forms of familial hyperaldosteronism: autosomal dominant, gain-of-function variants in one of several genes, CACNA1H, CACNA1D, CLCN2, and KCNJ5 [1215]. These genes are expressed in the adrenal gland and result in increased aldosterone production.
 
Literatur
1.
Zurück zum Zitat Rotin D, Staub O, Haguenauer-Tsapis R (2000) Ubiquitination and endocytosis of plasma membrane proteins: role of Nedd4/Rsp5p family of ubiquitin-protein ligases. J Membr Biol 176:1–17CrossRef Rotin D, Staub O, Haguenauer-Tsapis R (2000) Ubiquitination and endocytosis of plasma membrane proteins: role of Nedd4/Rsp5p family of ubiquitin-protein ligases. J Membr Biol 176:1–17CrossRef
2.
Zurück zum Zitat Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP (1994) Liddle’s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79:407–414CrossRef Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP (1994) Liddle’s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79:407–414CrossRef
3.
Zurück zum Zitat Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP (2001) Human hypertension caused by mutations in WNK kinases. Science 293:1107–1112CrossRef Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP (2001) Human hypertension caused by mutations in WNK kinases. Science 293:1107–1112CrossRef
4.
Zurück zum Zitat Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, Tikhonova IR, Bjornson R, Mane SM, Colussi G, Lebel M, Gordon RD, Semmekrot BA, Poujol A, Välimäki MJ, De Ferrari ME, Sanjad SA, Gutkin M, Karet FE, Tucci JR, Stockigt JR, Keppler-Noreuil KM, Porter CC, Anand SK, Whiteford ML, Davis ID, Dewar SB, Bettinelli A, Fadrowski JJ, Belsha CW, Hunley TE, Nelson RD, Trachtman H, Cole TR, Pinsk M, Bockenhauer D, Shenoy M, Vaidyanathan P, Foreman JW, Rasoulpour M, Thameem F, Al-Shahrouri HZ, Radhakrishnan J, Gharavi AG, Goilav B, Lifton RP (2012) Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482:98–102CrossRef Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, Tikhonova IR, Bjornson R, Mane SM, Colussi G, Lebel M, Gordon RD, Semmekrot BA, Poujol A, Välimäki MJ, De Ferrari ME, Sanjad SA, Gutkin M, Karet FE, Tucci JR, Stockigt JR, Keppler-Noreuil KM, Porter CC, Anand SK, Whiteford ML, Davis ID, Dewar SB, Bettinelli A, Fadrowski JJ, Belsha CW, Hunley TE, Nelson RD, Trachtman H, Cole TR, Pinsk M, Bockenhauer D, Shenoy M, Vaidyanathan P, Foreman JW, Rasoulpour M, Thameem F, Al-Shahrouri HZ, Radhakrishnan J, Gharavi AG, Goilav B, Lifton RP (2012) Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482:98–102CrossRef
5.
Zurück zum Zitat Ostrosky-Frid M, Castaneda-Bueno M, Gamba G (2019) Regulation of the renal NaCl cotransporter by the WNK/SPAK pathway: lessons learned from genetically altered animals. Am J Physiol Ren Physiol 316:F146–F158CrossRef Ostrosky-Frid M, Castaneda-Bueno M, Gamba G (2019) Regulation of the renal NaCl cotransporter by the WNK/SPAK pathway: lessons learned from genetically altered animals. Am J Physiol Ren Physiol 316:F146–F158CrossRef
6.
Zurück zum Zitat Gomez-Sanchez E, Gomez-Sanchez CE (2014) The multifaceted mineralocorticoid receptor. Compr Physiol 4:965–994CrossRef Gomez-Sanchez E, Gomez-Sanchez CE (2014) The multifaceted mineralocorticoid receptor. Compr Physiol 4:965–994CrossRef
7.
Zurück zum Zitat Wilson RC, Dave-Sharma S, Wei JQ, Obeyesekere VR, Li K, Ferrari P, Krozowski ZS, Shackleton CH, Bradlow L, Wiens T, New MI (1998) A genetic defect resulting in mild low-renin hypertension. Proc Natl Acad Sci U S A 95:10200–10205CrossRef Wilson RC, Dave-Sharma S, Wei JQ, Obeyesekere VR, Li K, Ferrari P, Krozowski ZS, Shackleton CH, Bradlow L, Wiens T, New MI (1998) A genetic defect resulting in mild low-renin hypertension. Proc Natl Acad Sci U S A 95:10200–10205CrossRef
8.
Zurück zum Zitat Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, Lifton RP (2000) Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289:119–123CrossRef Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, Lifton RP (2000) Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289:119–123CrossRef
9.
Zurück zum Zitat Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (1992) A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262–265CrossRef Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (1992) A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262–265CrossRef
10.
Zurück zum Zitat Peterson RE, Imperato-McGinley J, Gautier T, Shackleton C (1985) Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. N Engl J Med 313:1182–1191CrossRef Peterson RE, Imperato-McGinley J, Gautier T, Shackleton C (1985) Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. N Engl J Med 313:1182–1191CrossRef
11.
Zurück zum Zitat Chua SC, Szabo P, Vitek A, Grzeschik KH, John M, White PC (1987) Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11). Proc Natl Acad Sci U S A 84:7193–7197CrossRef Chua SC, Szabo P, Vitek A, Grzeschik KH, John M, White PC (1987) Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11). Proc Natl Acad Sci U S A 84:7193–7197CrossRef
12.
Zurück zum Zitat Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768–772CrossRef Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768–772CrossRef
13.
Zurück zum Zitat Scholl UI, Stölting G, Nelson-Williams C, Vichot AA, Choi M, Loring E, Prasad ML, Goh G, Carling T, Juhlin CC, Quack I, Rump LC, Thiel A, Lande M, Frazier BG, Rasoulpour M, Bowlin DL, Sethna CB, Trachtman H, Fahlke C, Lifton RP (2015) Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife 4:e06315CrossRef Scholl UI, Stölting G, Nelson-Williams C, Vichot AA, Choi M, Loring E, Prasad ML, Goh G, Carling T, Juhlin CC, Quack I, Rump LC, Thiel A, Lande M, Frazier BG, Rasoulpour M, Bowlin DL, Sethna CB, Trachtman H, Fahlke C, Lifton RP (2015) Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife 4:e06315CrossRef
14.
Zurück zum Zitat Scholl UI, Goh G, Stölting G, de Oliveira RC, Choi M, Overton JD, Fonseca AL, Korah R, Starker LF, Kunstman JW, Prasad ML, Hartung EA, Mauras N, Benson MR, Brady T, Shapiro JR, Loring E, Nelson-Williams C, Libutti SK, Mane S, Hellman P, Westin G, Åkerström G, Björklund P, Carling T, Fahlke C, Hidalgo P, Lifton RP (2013) Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet 45:1050–1054CrossRef Scholl UI, Goh G, Stölting G, de Oliveira RC, Choi M, Overton JD, Fonseca AL, Korah R, Starker LF, Kunstman JW, Prasad ML, Hartung EA, Mauras N, Benson MR, Brady T, Shapiro JR, Loring E, Nelson-Williams C, Libutti SK, Mane S, Hellman P, Westin G, Åkerström G, Björklund P, Carling T, Fahlke C, Hidalgo P, Lifton RP (2013) Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet 45:1050–1054CrossRef
15.
Zurück zum Zitat Scholl UI, Stölting G, Schewe J, Thiel A, Tan H, Nelson-Williams C, Vichot AA, Jin SC, Loring E, Untiet V, Yoo T, Choi J, Xu S, Wu A, Kirchner M, Mertins P, Rump LC, Onder AM, Gamble C, McKenney D, Lash RW, Jones DP, Chune G, Gagliardi P, Choi M, Gordon R, Stowasser M, Fahlke C, Lifton RP (2018) CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nat Genet 50:349–354CrossRef Scholl UI, Stölting G, Schewe J, Thiel A, Tan H, Nelson-Williams C, Vichot AA, Jin SC, Loring E, Untiet V, Yoo T, Choi J, Xu S, Wu A, Kirchner M, Mertins P, Rump LC, Onder AM, Gamble C, McKenney D, Lash RW, Jones DP, Chune G, Gagliardi P, Choi M, Gordon R, Stowasser M, Fahlke C, Lifton RP (2018) CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nat Genet 50:349–354CrossRef
16.
Zurück zum Zitat Mansilla MA, Sompallae RR, Nishimura CJ, Kwitek AE, Kimble MJ, Freese ME, Campbell CA, Smith RJ, Thomas CP (2019) Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfz173 Mansilla MA, Sompallae RR, Nishimura CJ, Kwitek AE, Kimble MJ, Freese ME, Campbell CA, Smith RJ, Thomas CP (2019) Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases. Nephrol Dial Transplant. https://​doi.​org/​10.​1093/​ndt/​gfz173
17.
Zurück zum Zitat Krapivinsky G, Gordon EA, Wickman K, Velimirovic B, Krapivinsky L, Clapham DE (1995) The G-protein-gated atrial K+ channel IKACh is a heteromultimer of two inwardly rectifying K(+)-channel proteins. Nature 374:135–141CrossRef Krapivinsky G, Gordon EA, Wickman K, Velimirovic B, Krapivinsky L, Clapham DE (1995) The G-protein-gated atrial K+ channel IKACh is a heteromultimer of two inwardly rectifying K(+)-channel proteins. Nature 374:135–141CrossRef
18.
Zurück zum Zitat Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M, Lifton RP (2008) A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 93:3117–3123CrossRef Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M, Lifton RP (2008) A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 93:3117–3123CrossRef
19.
20.
Zurück zum Zitat Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD (2010) Laboratory investigation of primary aldosteronism. Clin Biochem Rev 31:39–56PubMedPubMedCentral Stowasser M, Taylor PJ, Pimenta E, Ahmed AH, Gordon RD (2010) Laboratory investigation of primary aldosteronism. Clin Biochem Rev 31:39–56PubMedPubMedCentral
21.
Zurück zum Zitat Martinez-Aguayo A, Aglony M, Campino C, Garcia H, Bancalari R, Bolte L, Avalos C, Loureiro C, Carvajal CA, Avila A, Perez V, Inostroza A, Fardella CE (2010) Aldosterone, plasma renin activity, and aldosterone/renin ratio in a normotensive healthy pediatric population. Hypertension 56:391–396CrossRef Martinez-Aguayo A, Aglony M, Campino C, Garcia H, Bancalari R, Bolte L, Avalos C, Loureiro C, Carvajal CA, Avila A, Perez V, Inostroza A, Fardella CE (2010) Aldosterone, plasma renin activity, and aldosterone/renin ratio in a normotensive healthy pediatric population. Hypertension 56:391–396CrossRef
22.
Zurück zum Zitat Velarde-Miranda C, Gomez-Sanchez EP, Gomez-Sanchez CE (2013) Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel. Clin Exp Pharmacol Physiol 40:895–901CrossRef Velarde-Miranda C, Gomez-Sanchez EP, Gomez-Sanchez CE (2013) Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel. Clin Exp Pharmacol Physiol 40:895–901CrossRef
23.
Zurück zum Zitat Spat A, Hunyady L (2004) Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84:489–539CrossRef Spat A, Hunyady L (2004) Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84:489–539CrossRef
24.
Zurück zum Zitat McEwan PE, Lindop GB, Kenyon CJ (1996) Control of cell proliferation in the rat adrenal gland in vivo by the renin-angiotensin system. Am J Phys 271:E192–E198 McEwan PE, Lindop GB, Kenyon CJ (1996) Control of cell proliferation in the rat adrenal gland in vivo by the renin-angiotensin system. Am J Phys 271:E192–E198
25.
Zurück zum Zitat Mulatero P, Monticone S, Rainey WE, Veglio F, Williams TA (2013) Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol 9:104–112CrossRef Mulatero P, Monticone S, Rainey WE, Veglio F, Williams TA (2013) Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol 9:104–112CrossRef
26.
Zurück zum Zitat Roux B (2005) Ion conduction and selectivity in K(+) channels. Annu Rev Biophys Biomol Struct 34:153–171CrossRef Roux B (2005) Ion conduction and selectivity in K(+) channels. Annu Rev Biophys Biomol Struct 34:153–171CrossRef
27.
Zurück zum Zitat Charmandari E, Sertedaki A, Kino T, Merakou C, Hoffman DA, Hatch MM, Hurt DE, Lin L, Xekouki P, Stratakis CA, Chrousos GP (2012) A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension. J Clin Endocrinol Metab 97:E1532–E1539CrossRef Charmandari E, Sertedaki A, Kino T, Merakou C, Hoffman DA, Hatch MM, Hurt DE, Lin L, Xekouki P, Stratakis CA, Chrousos GP (2012) A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension. J Clin Endocrinol Metab 97:E1532–E1539CrossRef
28.
Zurück zum Zitat Scholl UI, Nelson-Williams C, Yue P, Grekin R, Wyatt RJ, Dillon MJ, Couch R, Hammer LK, Harley FL, Farhi A, Wang WH, Lifton RP (2012) Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc Natl Acad Sci U S A 109:2533–2538CrossRef Scholl UI, Nelson-Williams C, Yue P, Grekin R, Wyatt RJ, Dillon MJ, Couch R, Hammer LK, Harley FL, Farhi A, Wang WH, Lifton RP (2012) Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc Natl Acad Sci U S A 109:2533–2538CrossRef
29.
Zurück zum Zitat Mulatero P, Tauber P, Zennaro MC, Monticone S, Lang K, Beuschlein F, Fischer E, Tizzani D, Pallauf A, Viola A, Amar L, Williams TA, Strom TM, Graf E, Bandulik S, Penton D, Plouin PF, Warth R, Allolio B, Jeunemaitre X, Veglio F, Reincke M (2012) KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension 59:235–240CrossRef Mulatero P, Tauber P, Zennaro MC, Monticone S, Lang K, Beuschlein F, Fischer E, Tizzani D, Pallauf A, Viola A, Amar L, Williams TA, Strom TM, Graf E, Bandulik S, Penton D, Plouin PF, Warth R, Allolio B, Jeunemaitre X, Veglio F, Reincke M (2012) KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension 59:235–240CrossRef
30.
Zurück zum Zitat Dibb KM, Rose T, Makary SY, Claydon TW, Enkvetchakul D, Leach R, Nichols CG, Boyett MR (2003) Molecular basis of ion selectivity, block, and rectification of the inward rectifier Kir3.1/Kir3.4 K(+) channel. J Biol Chem 278:49537–49548CrossRef Dibb KM, Rose T, Makary SY, Claydon TW, Enkvetchakul D, Leach R, Nichols CG, Boyett MR (2003) Molecular basis of ion selectivity, block, and rectification of the inward rectifier Kir3.1/Kir3.4 K(+) channel. J Biol Chem 278:49537–49548CrossRef
31.
Zurück zum Zitat Monticone S, Bandulik S, Stindl J, Zilbermint M, Dedov I, Mulatero P, Allgaeuer M, Lee CCR, Stratakis CA, Williams TA, Tiulpakov A (2015) A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue. J Clin Endocrinol Metab 100:E114–E118CrossRef Monticone S, Bandulik S, Stindl J, Zilbermint M, Dedov I, Mulatero P, Allgaeuer M, Lee CCR, Stratakis CA, Williams TA, Tiulpakov A (2015) A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue. J Clin Endocrinol Metab 100:E114–E118CrossRef
Metadaten
Titel
A rare case of hyporeninemic hypertension: Answers
verfasst von
Ahmad Mashmoushi
Abha Choudhary
Christie P. Thomas
Matthias T. F. Wolf
Publikationsdatum
30.06.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 3/2021
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-020-04667-4

Weitere Artikel der Ausgabe 3/2021

Pediatric Nephrology 3/2021 Zur Ausgabe

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.